Holen Sie sich die Stockscreener-App
7.31
0.27%
0.02
Ocular Therapeutix Inc Aktie (OCUL) Neueste Nachrichten
Ocular Therapeutix™ to Participate in November Investor and Scientific Conferences - Yahoo! Finance Canada
Weekly Recap: AXPAXLI 505(b)(2) NDA filing and $600M cash runway - TradingView
Ocular Therapeutix: The Drug Won, The Stock Lost, And That's The Opportunity - Seeking Alpha
Ocular Therapeutix, Inc. Estimates – NASDAQ:OCUL - TradingView
Ocular Therapeutix at chardan healthcare conference: wet amd push advances - Investing.com Nigeria
Ocular Therapeutix Has 75% Success Probability for Axpaxli in Wet Age-Related Macular Degeneration, UBS Says - marketscreener.com
Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Win - Yahoo Finance
Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Win - TradingView
Ocular Therapeutix Eyes Q4 FDA Filing for AXPAXLI After SOL-1 Win - TradingView
Ocular Therapeutix at chardan healthcare conference: wet amd push advances - Investing.com
Ocular Therapeutix, Inc. (OCUL) options chain - Yahoo Finance Australia
Ocular Therapeutix stock hits 52-week low at 6.23 USD By Investing.com - Investing.com Nigeria
Ocular Therapeutix stock hits 52-week low at 6.23 USD By Investing.com - Investing.com South Africa
Ocular Therapeutix stock hits 52-week low at 6.23 USD - Investing.com
Novavax, Ocular Therapeutix, and QuidelOrtho Shares Plummet, What You Need To Know - Yahoo Finance
OCULAR THERAPEUTIX, INC. Announces Resignation of Sanjay Nayak as Chief Strategy Officer, Effective October 16, 2026 - www.marketscreener.com
Ocular Therapeutix, Inc. (OCUL) Presents at American Academy of Ophthalmology Retina Subspeciality DaySlideshow (NASDAQ:OCUL) 2026-10-15 - Seeking Alpha
Long term debt to total equity ratio of Ocular Therapeutix Inc – HAN:0OT - TradingView
Ocular Therapeutix CLO Todd Anderman sells $87,363 in company stock - Investing.com
Form 4 Ocular Therapeutix Inc: Todd Anderman (CLO) For: 8 October - Investing.com Nigeria
Form 4 Ocular Therapeutix Inc: Todd Anderman (CLO) For: 8 October - Investing.com India
To cover vesting taxes, Ocular Therapeutix (OCUL) legal chief sold 11,984 shares. - Stock Titan
Ocular Therapeutix Initiated at Buy by UBS - Moomoo
UBS Initiates Coverage on Ocular Therapeutix With Buy Rating, $14 Price Target - Moomoo
UBS initiates Ocular Therapeutix stock with buy rating on Axpaxli potential - Investing.com Canada
UBS initiates Ocular Therapeutix stock with buy rating on Axpaxli potential - Investing.com
Total debt per share of Ocular Therapeutix Inc – HAN:0OT - TradingView
OCUL Stock In Spotlight After Q2 Loss Comes In Narrower Than Estimated – A Look At Key Highlights - Stocktwits
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance
15 new hires receive stock awards from Ocular Therapeutix - Stock Titan
Officer Todd Anderman proposes selling 11,984 shares of Ocular Therapeutix (OCUL). - Stock Titan
Form 4 Ocular Therapeutix Inc For: 6 October By Investing.com - Investing.com Nigeria
Ocular Therapeutix, Inc. (OCUL) Presents at Euretina 2026Slideshow (NASDAQ:OCUL) 2026-10-06 - Seeking Alpha
Ocular Therapeutix CDO Peter Kaiser sells $70,429 in stock - Investing.com
An automatic tax-related sale of 9,990 shares at Ocular Therapeutix (OCUL) was not discretionary. - Stock Titan
To cover taxes, Ocular Therapeutix (OCUL) officer Heier sold 10,869 shares under automatic instructions. - Stock Titan
After stock vesting, an officer proposes selling 9,990 Ocular Therapeutix (OCUL) shares. - Stock Titan
Officer Jeffrey S. Heier proposes selling 10,869 Ocular Therapeutix (Nasdaq: OCUL) shares. - Stock Titan
Ocular Therapeutix (NasdaqGM:OCUL) Stock Forecast & Analyst Predictions - Simply Wall Street
Ocular Therapeutix (OCUL) Stock Still Looks Pricey As 145% Gain Draws Scrutiny - Yahoo Finance
OCUL Stock On Track For Worst Week In 2.5 Years As Rivals Raise The Bar In Wet AMD - Yahoo Finance
Ocular Therapeutix™ to Participate in October Scientific and Investor Conferences - Yahoo Finance
A Phase 3 eye-treatment trial is set for an October results presentation - Stock Titan
Operating income of Ocular Therapeutix Inc – HAN:0OT - TradingView
RBC Capital reiterates Ocular Therapeutix stock rating on wAMD treatment potential - Investing.com Nigeria
ETFs Investing in Ocular Therapeutix Inc Stocks - TradingView
Ocular Therapeutix, Inc. (OCUL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Precision Trading with Ocular Therapeutix Inc. (OCUL) Risk Zones - Stock Traders Daily
OCUL Stock Is Climbing Ahead Of Investor Day — What Is On The Agenda? - Stocktwits
Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst? - AlphaStreet
4.11%
2.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):